ARTICLE | Company News
Cadila Pharmaceuticals, Pergamum deal
February 18, 2013 8:00 AM UTC
The companies partnered to develop and commercialize an undisclosed therapeutic peptide to treat infectious diseases. Development of the compound will be conducted at Cadila, which will be responsible...